These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2835701

  • 1. LY164929: a highly selective ligand for the lower affinity [3H]D-Ala2-D-Leu-5-enkephalin binding site.
    Rothman RB, Bykov V, Ofri D, Rice KC.
    Neuropeptides; 1988 Jan; 11(1):13-6. PubMed ID: 2835701
    [Abstract] [Full Text] [Related]

  • 2. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA, Lutz RA, Munson PJ, Rodbard D.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [Abstract] [Full Text] [Related]

  • 3. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site.
    Cotton R, Kosterlitz HW, Paterson SJ, Rance MJ, Traynor JR.
    Br J Pharmacol; 1985 Apr; 84(4):927-32. PubMed ID: 2988685
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.
    Barrett RW, Vaught JL.
    Life Sci; 1983 Dec 12; 33(24):2439-48. PubMed ID: 6316063
    [Abstract] [Full Text] [Related]

  • 5. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA, Houghten R, Pasternak GW.
    Mol Pharmacol; 1988 Sep 12; 34(3):308-17. PubMed ID: 2901663
    [Abstract] [Full Text] [Related]

  • 6. Morphine tolerance increases mu-noncompetitive delta binding sites.
    Rothman RB, Danks JA, Jacobson AE, Burke TR, Rice KC, Tortella FC, Holaday JW.
    Eur J Pharmacol; 1986 May 13; 124(1-2):113-9. PubMed ID: 3013657
    [Abstract] [Full Text] [Related]

  • 7. Opioid ligand binding sites in the spinal cord of the guinea-pig.
    Zarr GD, Werling LL, Brown SR, Cox BM.
    Neuropharmacology; 1986 May 13; 25(5):471-80. PubMed ID: 3016586
    [Abstract] [Full Text] [Related]

  • 8. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB, Bowen WD, Herkenham M, Jacobson AE, Rice KC, Pert CB.
    Mol Pharmacol; 1985 Mar 13; 27(3):399-409. PubMed ID: 2579319
    [Abstract] [Full Text] [Related]

  • 9. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
    Rothman RB, Bykov V, Long JB, Brady LS, Jacobson AE, Rice KC, Holaday JW.
    Eur J Pharmacol; 1989 Jan 24; 160(1):71-82. PubMed ID: 2540993
    [Abstract] [Full Text] [Related]

  • 10. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).
    Spain JW, Roth BL, Coscia CJ.
    J Neurosci; 1985 Mar 24; 5(3):584-8. PubMed ID: 2983043
    [Abstract] [Full Text] [Related]

  • 11. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 24; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 12. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
    Akiyama K, Gee KW, Mosberg HI, Hruby VJ, Yamamura HI.
    Proc Natl Acad Sci U S A; 1985 Apr 24; 82(8):2543-7. PubMed ID: 2986120
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A, Lewis ME, Khachaturian H, Akil H, Watson SJ.
    Brain Res; 1986 Dec 03; 399(1):69-79. PubMed ID: 3026574
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL, Recht LD, Pasternak GW.
    Mol Pharmacol; 1984 Jan 03; 25(1):29-37. PubMed ID: 6323950
    [Abstract] [Full Text] [Related]

  • 19. Sulfonic acid enkephalin: binding specificity to rat brain opiate receptors.
    Martin JL, Coletti-Previero MA, Roques BP, Descomps B.
    Neuropeptides; 1985 Jul 03; 6(4):293-302. PubMed ID: 2995863
    [Abstract] [Full Text] [Related]

  • 20. Tritiated-6-beta-fluoro-6-desoxy-oxymorphone ([3H]FOXY): a new ligand and photoaffinity probe for the mu opioid receptors.
    Rothman RB, Bykov V, Rice KC, Jacobson AE, Kooper GN, Bowen WD.
    Neuropeptides; 1988 Jan 03; 11(1):1-6. PubMed ID: 2835700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.